Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Carlton

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Laryngoscope|March 3, 2015
In response to A systematic review of the quality of randomized controlled trials in head and neck oncology surgeryAlexander Langerman, Daniel A Carlton
Current Opinion in Otolaryngology & Head and Neck Surgery|December 23, 2016
Anesthesia for functional endoscopic sinus surgeryDaniel A Carlton, Satish Govindaraj
The Laryngoscope|November 9, 2018
Do preoperative corticosteroids benefit patients with chronic rhinosinusitis with nasal polyposis?Daniel A Carlton, Alexander G Chiu
The Laryngoscope|April 15, 2014
A systematic review of the quality of randomized controlled trials in head and neck oncology surgeryDaniel A Carlton, Masha Kocherginsky, Alexander J Langerman
American Journal of Otolaryngology|October 19, 2017
Malignant external otitis: The shifting treatment paradigmDaniel A Carlton, Enrique E Perez, Eric E Smouha
International Forum of Allergy & Rhinology|May 16, 2019
Topical antibiotic therapy in chronic rhinosinusitis: an updateDaniel A Carlton, D David Beahm, Alexander G Chiu
Laryngoscope Investigative Otolaryngology|April 27, 2019
Sinonasal malignancies: Endoscopic treatment outcomesDaniel A Carlton, D David Beahm, Alexander G Chiu
The Laryngoscope|July 8, 2016
Endoscopic-assisted transmastoid decompression of petrous apex cholesterol granulomaDaniel A Carlton, Alfred Marc C Iloreta, Sujana S Chandrasekhar
The Laryngoscope|April 14, 2017
In response to Endoscopic-assisted transmastoid decompression of petrous apex cholesterol granulomaSujana S Chandrasekhar, Daniel A Carlton, Alfred Marc C Iloreta
Biochimica Et Biophysica Acta|March 6, 2012
The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levelsRobert M Sargis, Brian A Neel, Clifton O Brock, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Laryngoscope|March 3, 2015
In response to A systematic review of the quality of randomized controlled trials in head and neck oncology surgeryAlexander Langerman, Daniel A Carlton
Current Opinion in Otolaryngology & Head and Neck Surgery|December 23, 2016
Anesthesia for functional endoscopic sinus surgeryDaniel A Carlton, Satish Govindaraj
The Laryngoscope|November 9, 2018
Do preoperative corticosteroids benefit patients with chronic rhinosinusitis with nasal polyposis?Daniel A Carlton, Alexander G Chiu
The Laryngoscope|April 15, 2014
A systematic review of the quality of randomized controlled trials in head and neck oncology surgeryDaniel A Carlton, Masha Kocherginsky, Alexander J Langerman
American Journal of Otolaryngology|October 19, 2017
Malignant external otitis: The shifting treatment paradigmDaniel A Carlton, Enrique E Perez, Eric E Smouha
International Forum of Allergy & Rhinology|May 16, 2019
Topical antibiotic therapy in chronic rhinosinusitis: an updateDaniel A Carlton, D David Beahm, Alexander G Chiu
Laryngoscope Investigative Otolaryngology|April 27, 2019
Sinonasal malignancies: Endoscopic treatment outcomesDaniel A Carlton, D David Beahm, Alexander G Chiu
The Laryngoscope|July 8, 2016
Endoscopic-assisted transmastoid decompression of petrous apex cholesterol granulomaDaniel A Carlton, Alfred Marc C Iloreta, Sujana S Chandrasekhar
The Laryngoscope|April 14, 2017
In response to Endoscopic-assisted transmastoid decompression of petrous apex cholesterol granulomaSujana S Chandrasekhar, Daniel A Carlton, Alfred Marc C Iloreta
Biochimica Et Biophysica Acta|March 6, 2012
The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levelsRobert M Sargis, Brian A Neel, Clifton O Brock, et al.
Pageof 1